company background image
DEVA logo

Deva Holding IBSE:DEVA Stock Report

Last Price

₺67.10

Market Cap

₺13.4b

7D

-1.5%

1Y

-22.2%

Updated

20 Nov, 2024

Data

Company Financials

DEVA Stock Overview

Manufactures, markets, and sells pharmaceutical products in Turkey. More details

DEVA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends1/6

Deva Holding A.S. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Deva Holding
Historical stock prices
Current Share Price₺67.10
52 Week High₺106.00
52 Week Low₺60.85
Beta-0.054
11 Month Change1.51%
3 Month Change-5.49%
1 Year Change-22.25%
33 Year Change130.74%
5 Year Change751.52%
Change since IPO35,612.00%

Recent News & Updates

Recent updates

Shareholder Returns

DEVATR PharmaceuticalsTR Market
7D-1.5%-1.8%-1.7%
1Y-22.2%8.0%6.4%

Return vs Industry: DEVA underperformed the TR Pharmaceuticals industry which returned 6.9% over the past year.

Return vs Market: DEVA underperformed the TR Market which returned 8.2% over the past year.

Price Volatility

Is DEVA's price volatile compared to industry and market?
DEVA volatility
DEVA Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement6.1%
10% most volatile stocks in TR Market8.9%
10% least volatile stocks in TR Market4.6%

Stable Share Price: DEVA has not had significant price volatility in the past 3 months compared to the TR market.

Volatility Over Time: DEVA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19583,023Philipp Haaswww.deva.com.tr

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary systems, connective tissue, and sensory organs; and veterinary medicines.

Deva Holding A.S. Fundamentals Summary

How do Deva Holding's earnings and revenue compare to its market cap?
DEVA fundamental statistics
Market cap₺13.42b
Earnings (TTM)₺3.15b
Revenue (TTM)₺11.00b

4.3x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DEVA income statement (TTM)
Revenue₺11.00b
Cost of Revenue₺5.05b
Gross Profit₺5.95b
Other Expenses₺2.80b
Earnings₺3.15b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)15.77
Gross Margin54.11%
Net Profit Margin28.68%
Debt/Equity Ratio31.9%

How did DEVA perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

2%

Payout Ratio